ZURICH (Reuters) – Swiss drugmaker Novartis (NOVN.S) is betting on heart drug prospect inclisiran in a $9.7 billion takeover of The Medicines Co (MDCO.O) as it challenges cardiovascular medicines from Amgen Inc (AMGN.O), Sanofi (SASY.PA) and Regeneron Pharmace... More »
BRUSSELS (Reuters) – As the Oct. 31 deadline for Britain to leave the European Union approaches, health professionals are warning that shortages of some medicines could worsen in Europe in the event of a no-deal Brexit. Britain’s food and drink lobby warned la... More »
The U.S. Food and Drug Administration said on Tuesday it has approved Medicines Co's antibacterial drug for patients with complicated urinary tract infections (cUTI). More »
By Lisa Rapaport(Reuters Health) – Studies drug companies fund after medicines go on sale may be too small to detect rare side effects, a recent Germ More »
